Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.

Westhoff C, Kaunitz AM, Korver T, Sommer W, Bahamondes L, Darney P, Verhoeven C.

Obstet Gynecol. 2012 May;119(5):989-99. doi: 10.1097/AOG.0b013e318250c3a0.

PMID:
22525910
2.

Nomegestrol acetate/estradiol: in oral contraception.

Yang LP, Plosker GL.

Drugs. 2012 Oct 1;72(14):1917-28. doi: 10.2165/11208180-000000000-00000.

PMID:
22950535
3.

Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.

Mansour D, Verhoeven C, Sommer W, Weisberg E, Taneepanichskul S, Melis GB, Sundström-Poromaa I, Korver T.

Eur J Contracept Reprod Health Care. 2011 Dec;16(6):430-43. doi: 10.3109/13625187.2011.614029. Epub 2011 Oct 13.

4.

Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.

Kaunitz AM, Burkman RT, Fisher AC, Laguardia KD.

Obstet Gynecol. 2009 Dec;114(6):1205-12. doi: 10.1097/AOG.0b013e3181beab47.

PMID:
19935020
5.

A new contraceptive pill containing 17β-estradiol and nomegestrol acetate.

Christin-Maitre S, Laroche E, Bricaire L.

Womens Health (Lond Engl). 2013 Jan;9(1):13-23. doi: 10.2217/whe.12.70. Review.

PMID:
23241152
7.

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.

Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.

Contraception. 1999 Nov;60(5):269-74.

PMID:
10717778
8.

Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study.

Christin-Maitre S, Serfaty D, Chabbert-Buffet N, Ochsenbein E, Chassard D, Thomas JL.

Hum Reprod. 2011 Jun;26(6):1338-47. doi: 10.1093/humrep/der058. Epub 2011 Mar 18.

9.

Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen.

Brucker C, Hedon B, The HS, Höschen K, Binder N, Christoph A.

Contraception. 2010 Jun;81(6):501-9. doi: 10.1016/j.contraception.2010.01.011. Epub 2010 Feb 19.

PMID:
20472117
10.

Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.

Sørdal T, Grob P, Verhoeven C.

Acta Obstet Gynecol Scand. 2012 Nov;91(11):1279-85. doi: 10.1111/j.1600-0412.2012.01498.x. Epub 2012 Aug 21.

PMID:
22762147
11.

Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.

Gaussem P, Alhenc-Gelas M, Thomas JL, Bachelot-Loza C, Remones V, Ali FD, Aiach M, Scarabin PY.

Thromb Haemost. 2011 Mar;105(3):560-7. doi: 10.1160/TH10-05-0327. Epub 2011 Jan 12.

PMID:
21225090
13.

Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study.

Jensen JT, Garie SG, Trummer D, Elliesen J.

Contraception. 2012 Aug;86(2):110-8. doi: 10.1016/j.contraception.2011.12.009. Epub 2012 Jan 26.

PMID:
22281416
14.

[Combined hormonal contraception in cycles artificially extended].

Bustillos-Alamilla E, Zepeda-Zaragoza J, Hernández-Ruiz MA, Briones-Landa CH.

Ginecol Obstet Mex. 2010 Jan;78(1):37-45. Spanish.

PMID:
20931801
15.

Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.

Ahrendt HJ, Nisand I, Bastianelli C, Gómez MA, Gemzell-Danielsson K, Urdl W, Karskov B, Oeyen L, Bitzer J, Page G, Milsom I.

Contraception. 2006 Dec;74(6):451-7. Epub 2006 Sep 27.

PMID:
17157101
16.
17.

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.

Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.

Contraception. 2009 Nov;80(5):436-44. doi: 10.1016/j.contraception.2009.03.018. Epub 2009 May 13.

PMID:
19835717
18.

Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.

Maloney JM, Dietze P Jr, Watson D, Niknian M, Lee-Rugh S, Sampson-Landers C, Korner P.

Obstet Gynecol. 2008 Oct;112(4):773-81. doi: 10.1097/AOG.0b013e318187e1c5.

PMID:
18827119
19.

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.

Huber J, Foidart JM, Wuttke W, Merki-Feld GS, The HS, Gerlinger C, Schellschmidt I, Heithecker R.

Eur J Contracept Reprod Health Care. 2000 Mar;5(1):25-34. Erratum in: Eur J Contracept Reprod Health Care 2001 Mar;6(1):63.

PMID:
10836660
20.

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.

Bachmann G, Sulak PJ, Sampson-Landers C, Benda N, Marr J.

Contraception. 2004 Sep;70(3):191-8.

PMID:
15325887
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk